Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002921081 | SCV003660552 | uncertain significance | Inborn genetic diseases | 2022-11-17 | criteria provided, single submitter | clinical testing | The c.12050A>G (p.H4017R) alteration is located in exon 61 (coding exon 60) of the USH2A gene. This alteration results from a A to G substitution at nucleotide position 12050, causing the histidine (H) at amino acid position 4017 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |